Anterix INC Form 4 insider transactions

William Heard, a Director of Anterix Inc., reported a transaction in 1,887 shares of common stock on December 29, 2025.

William Heard, a Director of Anterix Inc., received 1,598 shares of common stock on August 4, 2026.

Jeffrey A Altman and 1 other reported changes in beneficial ownership of Anterix Inc. common stock on August 4, 2026.

Mahvash Yazdi, a Director of Anterix Inc., received 1,598 shares of common stock on August 4, 2026.

Mark Fleischhauer, a Director of Anterix Inc., received 1,598 shares of common stock on August 4, 2026.

Leslie B Daniels, a Director of Anterix Inc., received 1,598 shares of common stock on August 4, 2026.

Elena Marquez, Chief Financial Officer of Anterix Inc., reported a transaction in 231 shares of common stock on July 13, 2026.

Christopher Guttman-Mccabe, Chief Reg & Comm Officer of Anterix Inc., reported a transaction in 1,516 shares of common stock on July 13, 2026.

Anterix Inc. files an amended Form 4 to correct a reporting error regarding beneficial ownership of stock options.

Anterix Inc. Chief Financial Officer Elena Marquez reported transactions involving the acquisition and disposition of company stock, alongside the exercise of stock options.

Anterix Chief Regulatory and Communications Officer Christopher Guttman-McCabe exercised options for 122,852 shares and sold 91,437 shares.

Anterix Inc. Chief Legal Officer Gena L. Ashe exercised stock options and sold a portion of the resulting shares.

Anterix Inc. President and CEO Scott Lang exercised stock options for 138,318 shares, resulting in a net increase in direct ownership.

Anterix Inc. Director Mark Fleischhauer sold 3,500 shares of common stock at an average price of $79.8294.

Anterix Inc. Director and 10% owner Mahvash Yazdi reported the sale of 7,000 common shares at $80 per share, executed under a pre-arranged 10b5-1 trading plan.

Gena L. Ashe, Chief Legal Officer & Corp Sec of Anterix Inc., reported a transaction involving the sale of 2,501 common shares.

Anterix Inc. President and CEO Scott Lang was granted 18,210 restricted stock units and 72,839 stock options on May 20, 2026.

Anterix Inc. Chief Legal Officer Gena L. Ashe was granted 3,694 restricted stock units and 17,453 stock options.

Chief Regulatory and Communications Officer Christopher Guttman-McCabe was granted restricted stock units and stock options.

Anterix Inc. CFO Elena Marquez was granted 3,694 restricted stock units and 17,453 stock options as part of an equity compensation package.

Anterix Inc. Chief Marketing Officer Heather Martin was granted 3,694 restricted stock units and 17,453 stock options.

Anterix Inc. Chief Legal Officer Gena L. Ashe reported the withholding of 1,028 shares to satisfy tax obligations related to restricted stock unit vesting.

Anterix Inc. Chief Regulatory and Communications Officer Christopher Guttman-McCabe reported the withholding of 1,426 shares to satisfy tax obligations.

Anterix Inc. reports a Form 4 filing detailing a stock transaction by Chief Financial Officer Elena Marquez.

Anterix's Chief Legal Officer, Gena L. Ashe, exercised stock options and subsequently sold shares to cover related tax obligations.

Anterix Inc. President and CEO Scott A. Lang acquired 1,160 shares of common stock at $21.61 per share, increasing his direct beneficial ownership to 8,260 shares.

Anterix Inc. President and CEO, Scott A. Lang, acquired 2,450 shares of common stock at $20.41 per share, increasing his direct beneficial ownership to 7,100 shares.

Anterix Inc.'s Chief Legal Officer, Gena L. Ashe, reported the sale of 6,564 shares of common stock at $21.07 per share under a pre-arranged trading plan.

Anterix Inc.'s Chief Financial Officer, Elena Marquez, reported the acquisition of restricted stock units and the disposition of shares for tax withholding purposes.

Anterix Inc. President and CEO Scott A. Lang acquired 4,650 shares of common stock at $21.28 per share through a pre-arranged Rule 10b5-1 plan.